/Companies

RedAce Bio

1 known investors

Find your way into RedAce Bio

Sign up to see every warm intro you have to RedAce Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RedAce Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Red Ace is a biotech company developing cancer therapies using what it calls selection gene drive technology, delivering therapeutic gene circuits into tumor cells via tumor-targeted viral vectors. Its approach reprograms cancer cells with synthetic vulnerabilities to overcome drug resistance and work alongside existing oncology treatments.

Investors · 1

Frequently asked questions

What does RedAce Bio do?
Red Ace is a biotech company developing cancer therapies using what it calls selection gene drive technology, delivering therapeutic gene circuits into tumor cells via tumor-targeted viral vectors. Its approach reprograms cancer cells with synthetic vulnerabilities to overcome drug resistance and work alongside existing oncology treatments.
Who are RedAce Bio's investors?
RedAce Bio's investors include BoxOne Ventures.